Barclays Maintains Overweight on Visteon, Lowers Price Target to $125
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Barclays analyst Dan Levy maintains Visteon (NASDAQ:VC) with a Overweight and lowers the price target from $145 to $125.
Barclays analyst Dan Levy maintains Visteon (NASDAQ:VC) with a Overweight and lowers the price target from $145 to $125.